Higher serum levels of miR-33a and miR-455-3p indicated better response while high levels of miR-224 (target: CD59), miR-520d-3p and miR-1236 were connected with worse R-CHOP response in DLBCL patients[35,46]. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.